Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124898742 | 12489874 | 2 | F | 20160517 | 20160629 | 20160622 | 20160708 | EXP | JP-DEPOMED, INC.-JP-2016DEP010351 | DEPOMED | 61.43 | YR | F | Y | 64.00000 | KG | 20160708 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124898742 | 12489874 | 1 | PS | TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | 1 | Oral | 25 MG, QD | 275 | MG | Y | 22304 | 25 | MG | TABLET | ||||
| 124898742 | 12489874 | 2 | SS | TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | 1 | Oral | 25 MG, BID | 275 | MG | Y | 22304 | 25 | MG | TABLET | ||||
| 124898742 | 12489874 | 3 | SS | TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | 1 | Oral | 75 MG, BID | 275 | MG | Y | 22304 | 75 | MG | TABLET | ||||
| 124898742 | 12489874 | 4 | SS | TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | 1 | Oral | 25 MG, QD | 275 | MG | Y | 22304 | 25 | MG | TABLET | ||||
| 124898742 | 12489874 | 5 | SS | TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | 1 | Oral | 25 MG, BID | 275 | MG | Y | 22304 | 25 | MG | TABLET | ||||
| 124898742 | 12489874 | 6 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 2.5 MG, QD | 0 | 2.5 | MG | ||||||||
| 124898742 | 12489874 | 7 | SS | ARTIST | CARVEDILOL | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | |||||||
| 124898742 | 12489874 | 8 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124898742 | 12489874 | 9 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124898742 | 12489874 | 10 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124898742 | 12489874 | 11 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124898742 | 12489874 | 12 | C | FAMOTIDINE. | FAMOTIDINE | 1 | UNK | U | 0 | ||||||||||
| 124898742 | 12489874 | 13 | C | LOXOPROFEN SODIUM | LOXOPROFEN SODIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124898742 | 12489874 | 1 | Cancer pain |
| 124898742 | 12489874 | 6 | Prophylaxis |
| 124898742 | 12489874 | 7 | Hypertension |
| 124898742 | 12489874 | 8 | Cancer pain |
| 124898742 | 12489874 | 12 | Gastrooesophageal reflux disease |
| 124898742 | 12489874 | 13 | Cancer pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124898742 | 12489874 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124898742 | 12489874 | Cerebral infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124898742 | 12489874 | 1 | 20160519 | 20160519 | 0 | |
| 124898742 | 12489874 | 2 | 20160518 | 20160518 | 0 | |
| 124898742 | 12489874 | 3 | 20160517 | 20160517 | 0 | |
| 124898742 | 12489874 | 4 | 20160511 | 20160511 | 0 | |
| 124898742 | 12489874 | 5 | 20160512 | 20160516 | 0 | |
| 124898742 | 12489874 | 6 | 20160511 | 0 | ||
| 124898742 | 12489874 | 7 | 20160509 | 0 | ||
| 124898742 | 12489874 | 8 | 20160517 | 20160517 | 0 | |
| 124898742 | 12489874 | 9 | 20160514 | 20160514 | 0 | |
| 124898742 | 12489874 | 10 | 20160513 | 20160513 | 0 | |
| 124898742 | 12489874 | 11 | 20160511 | 20160511 | 0 | |
| 124898742 | 12489874 | 13 | 20160511 | 0 |